bf/NASDAQ:GILD_icon.png

COM:GILEAD

Gilead Sciences, Inc.

  • Stock

USD

Last Close

89.76

22/11 21:00

Market Cap

85.65B

Beta: -

Volume Today

4.43M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
1.90B
-
1.72B
9.44%
1.67B
2.93%
1.77B
6.02%
1.19B
32.58%
807.50M
32.37%
1.44B
78.39%
2.54B
76.36%
2.87B
13.13%
2.78B
3.38%
average payables
1.29B
-
1.11B
14.41%
1.07B
3.52%
1.19B
11.77%
1.01B
15.27%
802M
20.59%
751.50M
6.30%
778.50M
3.59%
774.50M
0.51%
805M
3.94%
average receivables
1.93B
-
3.37B
74.87%
5.24B
55.73%
5.18B
1.15%
4.18B
19.32%
3.59B
14.19%
3.45B
3.75%
4.24B
22.65%
4.69B
10.75%
4.63B
1.23%
book value per share
7.68
-
10.39
35.28%
13.06
25.61%
14.46
10.77%
15.69
8.47%
16.59
5.77%
17.83
7.50%
14.50
18.72%
16.77
15.69%
16.90
0.77%
capex per share
-0.12
-
-0.37
193.23%
-0.51
39.42%
-0.56
9.48%
-0.45
19.19%
-0.71
57.70%
-0.65
8.75%
-0.52
20.40%
-0.46
10.85%
-0.58
25.83%
capex to depreciation
-0.55
-
-0.53
4.15%
-0.68
28.25%
-0.65
5.05%
-0.46
28.97%
-0.65
40.94%
-0.59
9.12%
-0.44
25.26%
-0.28
35.69%
-0.35
22.57%
capex to operating cash flow
-0.06
-
-0.04
29.28%
-0.04
15.44%
-0.04
22.12%
-0.05
10.51%
-0.11
121.83%
-0.09
17.98%
-0.08
11.80%
-0.05
36.09%
-0.08
57.78%
capex to revenue
-0.02
-
-0.02
31.39%
-0.02
2.27%
-0.02
7.54%
-0.02
8.18%
-0.04
84.78%
-0.04
11.99%
-0.03
28.36%
-0.02
19.46%
-0.03
25.84%
cash per share
1.39
-
6.65
377.21%
9.98
49.94%
8.88
10.96%
19.52
119.71%
23.18
18.77%
19.17
17.28%
5.89
69.26%
5.19
11.92%
5.09
1.99%
days of inventory on hand
262.50
-
133.55
49.12%
178.13
33.38%
135.94
23.68%
66.89
50.80%
61.22
8.47%
161.38
163.60%
240.62
49.10%
151.18
37.17%
181.95
20.36%
days payables outstanding
160.37
-
92.02
42.62%
107.33
16.64%
103.31
3.75%
67.97
34.20%
59.42
12.59%
55.67
6.31%
67.38
21.04%
38.98
42.14%
58.39
49.79%
days sales outstanding
68.44
-
67.97
0.68%
65.46
3.69%
54.22
17.18%
53.84
0.69%
54.88
1.93%
58.24
6.12%
72.32
24.18%
60.06
16.96%
63.91
6.41%
debt to assets
0.18
-
0.34
93.54%
0.41
18.75%
0.44
7.04%
0.48
9.04%
0.43
10.09%
0.40
7.00%
0.46
15.03%
0.39
14.42%
0.40
1.67%
debt to equity
0.34
-
0.75
121.40%
1.11
46.98%
1.29
16.13%
1.64
27.04%
1.27
22.45%
1.09
14.42%
1.72
58.72%
1.27
26.46%
1.19
6.13%
dividend yield
0.02
-
0.04
194.39%
0.01
71.56%
0.03
102.40%
0.03
13.92%
0.04
25.46%
0.04
6.69%
0.05
20.63%
0.04
16.07%
0.03
12.91%
earnings yield
0.03
-
0.08
214.92%
0.12
44.91%
0.14
15.19%
0.05
64.90%
0.07
35.93%
0.07
2.86%
0.00
98.14%
0.07
5,516.54%
0.04
37.56%
0.06
31.47%
enterprise value
112.75B
-
133.45B
18.36%
135.29B
1.38%
114.00B
15.74%
119.59B
4.90%
90.57B
24.26%
95.49B
5.43%
98.64B
3.30%
112.56B
14.11%
127.56B
13.33%
enterprise value over ebitda
24.97
-
8.74
65.00%
6.05
30.73%
6.31
4.26%
8.16
29.35%
10.20
24.98%
15.51
52.03%
11.59
25.28%
11.90
2.68%
12.27
3.11%
ev to operating cash flow
36.31
-
10.41
71.33%
6.66
36.08%
6.84
2.77%
10.05
46.96%
10.78
7.28%
10.44
3.15%
12.08
15.64%
9.89
18.13%
14.06
42.21%
ev to sales
10.07
-
5.36
46.73%
4.15
22.69%
3.75
9.50%
4.58
22.11%
4.09
10.64%
4.25
3.91%
4.00
6.07%
4.12
3.18%
4.68
13.43%
free cash flow per share
1.91
-
8.06
322.56%
13.38
66.04%
11.89
11.11%
8.65
27.24%
5.76
33.43%
6.55
13.73%
5.98
8.69%
8.60
43.84%
6.65
22.71%
6.42
3.51%
free cash flow yield
0.03
-
0.09
236.67%
0.13
54.67%
0.17
25.61%
0.12
27.27%
0.09
23.75%
0.10
9.48%
0.10
1.84%
0.12
15.41%
0.08
34.63%
0.08
2.25%
graham net net
-3.94
-
-2.99
24.10%
-8.71
191.49%
-16.09
84.70%
-16.05
0.20%
-7.05
56.09%
-8.59
21.81%
-29.91
248.38%
-28.37
5.17%
-24.37
14.10%
graham number
18.65
-
43.12
131.24%
60.28
39.79%
57.28
4.98%
35.35
38.28%
39.61
12.04%
41.25
4.15%
4.81
88.35%
43.25
799.92%
37.30
13.75%
income quality
1.02
-
1.06
4.66%
1.12
5.63%
1.24
10.07%
2.56
107.31%
1.54
39.95%
1.70
10.81%
91.78
5,283.67%
1.84
98.00%
1.99
8.23%
intangibles to total assets
0.58
-
0.35
39.19%
0.22
37.64%
0.18
19.18%
0.30
69.91%
0.31
3.09%
0.29
6.83%
0.60
107.49%
0.61
2.02%
0.59
4.22%
0
100%
interest coverage
14.74
-
37.05
151.34%
32.26
12.94%
18.29
43.29%
12.63
30.93%
7.61
39.73%
4.31
43.41%
7.14
65.79%
7.40
3.57%
7.84
5.96%
-8.06
202.76%
interest debt per share
2.82
-
8.11
187.78%
14.95
84.26%
19.34
29.40%
26.52
37.09%
21.88
17.50%
20.15
7.91%
25.76
27.88%
22.05
14.41%
20.85
5.45%
inventory turnover
1.39
-
2.73
96.56%
2.05
25.02%
2.68
31.03%
5.46
103.24%
5.96
9.25%
2.26
62.06%
1.52
32.93%
2.41
59.17%
2.01
16.91%
invested capital
0.34
-
0.75
121.40%
1.11
46.98%
1.29
16.13%
1.64
27.04%
1.27
22.45%
1.09
14.42%
1.72
58.72%
1.27
26.46%
1.19
6.13%
market cap
114.80B
-
143.46B
24.97%
148.14B
3.26%
95.89B
35.27%
93.63B
2.35%
81.19B
13.29%
82.52B
1.64%
73.23B
11.26%
91.20B
24.53%
107.74B
18.14%
101.10B
6.16%
net current asset value
-4.03B
-
-1.10B
72.72%
1.29B
217.58%
867M
32.84%
-8.44B
1,073.01%
-6.49B
23.09%
-7.49B
15.41%
-34.37B
359.00%
-31.83B
7.38%
-26.73B
16.01%
net debt to ebitda
-0.45
-
-0.66
44.50%
-0.57
12.32%
1.00
274.46%
1.77
76.65%
1.06
40.35%
2.11
99.24%
2.99
41.77%
2.26
24.35%
1.91
15.57%
net income per share
2.01
-
7.95
295.26%
12.37
55.57%
10.08
18.48%
3.54
64.88%
4.20
18.69%
4.24
0.91%
0.07
98.33%
4.96
6,899.95%
3.66
26.17%
4.54
24.06%
operating cash flow per share
2.03
-
8.42
314.62%
13.89
64.88%
12.45
10.35%
9.10
26.87%
6.47
28.91%
7.20
11.26%
6.50
9.75%
9.06
39.48%
7.23
20.25%
6.42
11.26%
payables turnover
2.28
-
3.97
74.27%
3.40
14.26%
3.53
3.90%
5.37
51.98%
6.14
14.40%
6.56
6.74%
5.42
17.38%
9.36
72.85%
6.25
33.24%
receivables turnover
5.33
-
5.37
0.69%
5.58
3.83%
6.73
20.75%
6.78
0.70%
6.65
1.90%
6.27
5.77%
5.05
19.47%
6.08
20.42%
5.71
6.03%
research and ddevelopement to revenue
0.19
-
0.11
39.41%
0.09
19.47%
0.17
81.66%
0.14
14.74%
0.23
58.56%
0.41
78.86%
0.20
49.68%
0.20
3.77%
0.18
7.12%
0.21
15.59%
return on tangible assets
0.33
-
0.54
65.50%
0.45
17.00%
0.29
35.65%
0.09
67.25%
0.12
31.87%
0.12
1.05%
0.00
97.34%
0.24
7,163.84%
0.18
25.66%
revenue per share
7.33
-
16.35
123.17%
22.29
36.33%
22.70
1.80%
19.97
11.99%
17.05
14.66%
17.68
3.69%
19.64
11.12%
21.74
10.68%
21.74
0.01%
21.73
0.05%
roe
0.26
-
0.76
192.19%
0.95
23.85%
0.70
26.40%
0.23
67.62%
0.25
12.22%
0.24
6.13%
0.00
97.95%
0.30
5,950.35%
0.22
26.74%
roic
0.21
-
0.44
111.94%
0.46
4.06%
0.31
31.56%
0.09
71.53%
0.12
29.57%
0.09
19.73%
0.01
92.59%
0.11
1,562.81%
0.12
6.20%
sales general and administrative to revenue
0.15
-
0.12
21.00%
0.10
12.42%
0.11
6.52%
0.15
32.85%
0.18
23.40%
shareholders equity per share
7.68
-
10.39
35.28%
13.06
25.61%
14.46
10.77%
15.69
8.47%
16.59
5.77%
17.83
7.50%
14.50
18.72%
16.77
15.69%
16.90
0.77%
stock based compensation to revenue
0.02
-
0.01
35.70%
0.01
19.08%
0.01
6.84%
0.02
95.44%
0.04
56.27%
0.03
25.81%
0.03
8.07%
0.02
10.71%
0.02
0.40%
tangible asset value
-1.32B
-
3.57B
369.81%
7.69B
115.28%
9.22B
19.83%
-758M
108.22%
1.68B
321.50%
4.75B
182.73%
-23.01B
584.79%
-20.72B
9.95%
-16.00B
22.80%
tangible book value per share
-0.87
-
2.35
370.99%
5.26
123.81%
6.89
31.02%
-0.58
108.42%
1.29
323.04%
3.74
188.96%
-18.31
589.80%
-16.50
9.88%
-12.75
22.73%
working capital
401.14M
-
12.13B
2,923.66%
24.13B
98.91%
29.26B
21.29%
29.71B
1.53%
25.05B
15.69%
21.73B
13.25%
4.42B
79.66%
3.45B
22.02%
3.99B
15.79%

All numbers in USD (except ratios and percentages)